Natural killer (NK) cells are important early responders against viral infections. Changes in metabolism are crucial to fuel NK cell responses, and altered metabolism is linked to NK cell dysfunction in obesity and cancer. However, very little is known about the metabolic requirements of NK cells during acute retroviral infection and their importance for antiviral immunity. Here, using the Friend retrovirus mouse model, we show that following infection NK cells increase nutrient uptake, including amino acids and iron, and reprogram their metabolic machinery by increasing glycolysis and mitochondrial metabolism. Specific deletion of the amino acid transporter Slc7a5 has only discrete effects on NK cells, but iron deficiency profoundly impaires NK cell antiviral functions, leading to increased viral loads. Our study thus shows the requirement of nutrients and metabolism for the antiviral activity of NK cells, and has important implications for viral infections associated with altered iron levels such as HIV and SARS-CoV-2.
The best protection we have against viruses, such as polio, measles, and hepatitis A or B, are vaccines but the development of such vaccines takes time and in the case of the human immunodeficiency virus (HIV) an effective vaccine is still illusive. Natural killer (NK) cells are cytotoxic lymphocytes that have an important role in the early response against likely all viral infections1. Understanding how NK cells contribute to the initial immunity against retroviral infection has the potential to reveal novel strategies for antiretroviral therapy.
NK cells express an array of activating and inhibitory germline-encoded receptors and become activated by the integration of its receptor signals2. Activated NK cells eliminate target cells via the release of cytotoxic granules filled with granzymes and perforin and also express death receptor ligands (e.g. TRAIL, FasL), which can induce apoptosis in target cells after binding to its receptors1. Upon activation, NK cells also produce a large array of cytokines including Interferon (IFN) γ and Tumour necrosis factor (TNF). NK cells also become activated in response to cytokines including interleukin (IL)-2, IL-12, IL-15 and IL-18, and this is an important mode of NK cell activation during viral and retroviral infections3,4,5.
Recent research has demonstrated that once activated by cytokines, NK cells undergo distinct metabolic rearrangements that are essential for their effector functions including cytotoxicity and cytokine production6,7,8. This metabolic response involves the upregulation of nutrient transporters and metabolic enzymes and an increase in mitochondrial mass. Collectively, this facilitates increased flux through metabolic pathways including glycolysis and oxidative phosphorylation (OXPHOS) that allows for the production of energy in the form of ATP and an enhanced biosynthetic capacity. The transcription factor cMyc has been identified as a key regulator of these metabolic changes in activated NK cells7. Cytokine-activated NK cells are highly dependent on amino acids availability and are particularly reliant on the flux through the large neutral amino acid transporter Slc7a5, which supports metabolic signal transduction pathways including the protein expression of cMyc7. Iron is very important for essential cellular activities including mitochondrial function, DNA repair and synthesis, and epigenetic regulation and sensing of hypoxia9. In T cells, there is strong evidence that cMyc is important for the expression of the transferrin receptor (CD71), which is crucial for the uptake of ferric iron into cells10,11 and it was recently demonstrated that adaptive T cell immunity is critically dependent on serum iron availability12. The importance of iron for the function of innate lymphocytes is unknown, however concomitant with increased mitochondrial mass and respiration rates, activated NK cells increase the expression of CD717,8. Perturbations in NK cell metabolism have been described in multiple diseases including cancer and obesity and linked to impaired functional NK cell responses13. In the case of obesity, NK cells completely fail to increase levels of cellular metabolism in response to cytokines and have severely impaired cytotoxicity13. To date, the metabolic changes that occur in NK cells as they respond to acute retroviral infection and their importance in the overall control of retroviral burden have not been investigated.
Here, we used the Friend retrovirus (FV) mouse model to analyse the NK cell metabolism and NK cell functions after an acute retrovirus infection of mice. Friend virus complex consists of a replication-competent, but apathogenic F-MuLV (Friend Murine Leukaemia Virus) and the replication-defective but pathogenic SFFV (Spleen Focus-Forming Virus)14. Adult C57BL/6 mice are resistant to FV-induced disease and develop an early and strong immune response that controls viral replication, but fails to clear infection resulting in a lifelong chronic infection. In retrovirus infections, such as infections with FV, simian immunodeficiency virus (SIV) and HIV, NK cells play an important role in restricting virus replication in the acute phase15. Depleting NK cells in mice with acute FV infection has detrimental effects on the control of viral burden16. For NK cells activation the cytokines IL-15 and IL-18, produced by Dendritic cells (DCs) and macrophages, are necessary to limit the spread of FV4. Previous work has demonstrated that the antiretroviral activity of NK cells can be reduced by regulatory T cells through competition for IL-2 and the IL-10 production17,18. NK cells become dysfunctional during chronic infection but a small population of antigen-specific memory-like NK cells develop in retroviral infections as it was demonstrated for SIV and FV15,19,20. Thus, the FV infection is a good experimental model when analysing NK cells and metabolic requirements for their responses against retroviruses. In chronically HIV-infected individuals, co-infected with cytomegalovirus (CMV), NK cells show evidence of mitochondria dysfunction and reduced levels of OXPHOS21. Targeting immune cell metabolism is an extremely promising therapeutic approach that has been investigated for numerous immunological diseases22,23,24. However, almost nothing is known about the NK cell metabolic requirements and alterations in the acute phase of retroviral infection and so potential new therapies could be missed. The FV mouse model enables the detailed analysis of the metabolic changes that accompany early antiviral NK cell responses against retrovirus infection. The importance of NK cell metabolic processes for these antiviral responses can also be investigated following manipulation of metabolism in vivo.
Here, we show that NK cells reprogramme their metabolism by increasing their nutrient uptake, glycolysis and mitochondrial machinery after acute virus infection. The antiviral functions of NK cells strongly depend on sufficient levels of iron. This new understanding of the metabolism of NK cells in the acute phase of infection is essential to facilitate the development of novel metabolism-targeted approaches for treating infectious diseases.
Activated, cytokine-producing NK cells in FV-infected mice
C57BL/6 mice were infected with 40,000 Spleen Focus-Forming Units (SFFU) of FV and the viral loads in the bone marrow and spleens were monitored over the course of 28 days. The bone marrow and spleen were analysed due to high viral replication in these organs25. FV preferentially infects erythroblasts, monocytes and macrophages but all dividing cells in the spleen and bone marrow can be targets for infection26,27. As shown in Fig. 1a viral loads increased and peaked at 7 days post-infection (dpi) in both analysed organs. Viral loads were significantly higher in the bone marrow in comparison to the spleen. The viral burden was reduced at 12 dpi, correlating with the activation of the adaptive immune response against FV28. FV was not eradicated but was found to persist at 28 dpi and harbouring infected cells in low levels in bone marrow and spleen. To study the role of NK cells in FV immunity, we analysed the activation of NK cells during the course of infection15. The NK cell gating strategy is shown in Supplementary Fig. 1d. Activated NK cells express the early activation marker CD69 and can be analysed via flow cytometry. Activation of NK cells reached its maximum at 7 dpi and decreased at 12 dpi and 28 dpi in both organs (Fig. 1b). We further studied NK cells at the peak of the NK cell response (7 dpi), evaluating the NK cell maturation status by measuring the expression of CD11b and CD27 on the cell surface29. These molecules classify four stages of NK cells maturation: Double negative (CD27−CD11b− immature NK cells), CD27+CD11b− (immature cytokine producers), double-positive (CD27+CD11b+ mature cytokine producer) and CD27− CD11b+ (cytotoxic effector cells). At 7 dpi, the subpopulation of effector cells (CD27−CD11b+), as well as the subpopulation of immature NK cells (CD27−CD11b−), decreased (Fig. 1c). At the same time, we found a higher percentage of CD27+CD11b+ NK cells (mature cytokine producer) in both organs in comparison to NK cells from naive hosts (Fig. 1c). In line with these changes in subset frequencies, we detected an increased production of IFNγ and TNF and more cytokine positive NK cells in bone marrow (Fig. 1d) and spleen (Fig. 1e) at 7 dpi but similar levels of granzyme B expression (Fig. 1d, e). At 7 dpi, we analysed the NK cells positive for CD69, IFNγ, TNF or granzyme B for their subset maturation stage, again using CD27 and CD11b (Supplementary Fig. 1a). Most of the activated NK cells belong to the double-positive subset. Cytokines were produced mainly by the cytokine-producing subsets whereas granzyme B was expressed by mature cytokine producers and cytotoxic effector cells. NK cells from FV-infected mice were also found to express higher levels of the death receptor ligand FasL and KI-67, a marker of proliferating cells compared to naive cells (Fig. 1d, e). These results demonstrate that NK cells are highly activated and increase their cytokine production during acute FV infection.
FV infection induces metabolically active NK cells
Cellular growth, cell division and cytokine production are energetically demanding processes that require increased uptake of nutrients and a reprogramming of the metabolic machinery8. Considering that NK cells showed peak activation at 7 dpi, we predicted that this would be associated with metabolic changes in these NK cells. Thus, we addressed the question of whether acute FV infection induces metabolic changes in NK cells. We first analysed whether there was a change in cell size in the activated NK cells following FV infection through analysis of the forward scatter (FSC), as a measure of cell size, by flow cytometry (Fig. 2a, b). There was a clear shift in the FSC for NK cells from spleen and bone marrow upon FV infection, indicative of increased cell size. This increase in NK cell FSC correlated with NK cell activation, as measured by CD69 expression, suggesting that increased cell growth was associated with NK cell activation in FV-infected mice (Fig. 2c). To understand the processes underlying the apparent increase in the size of activated NK cells, we stratified the NK cells from FV-infected mice into FSChigh and FSClow populations and analysed the expression of important nutrient transporters. CD98 is a protein complex of a number of transporters for large neutral amino acids including (LAT1), where CD98 complexes with the pore-forming subunit Slc7a5. The transferrin receptor CD71 is an integral membrane glycoprotein important for the uptake of transferrin/iron. CD98 and CD71 expression was significantly increased on the FSChigh NK cell population from FV-infected mice (Fig. 2d, e). These increases in CD71 and CD98 expression were not simply because the NK cells were bigger as the expression proteins with no function in metabolism, including NK1.1, were equivalent between FSChigh and FSClow NK cell populations (Fig. 2d). In naive control mice, the proportion of FSChigh NK cells is very small. CD71 is a target of cMyc, which is an important general regulator of cellular metabolism and proliferation. It has been shown that cMyc is essential for the metabolic response of NK cells following their activation by cytokines7,30. cMyc can promote growth and proliferation through regulating a number of metabolic processes including glycolysis and the pentose phosphate pathway, a pathway branching off from glycolysis31. cMyc also promotes mitogenesis and OXPHOS in activated NK cells7. Together these pathways support the generation of ATP and the production of the biosynthetic molecule for the generation of protein, lipid and nucleotides. Indeed, cMyc expression was significantly increased in NK cells from FV-infected mice compared to naive mice in both bone marrow and spleen (Fig. 2f, g). cMyc was mainly expressed by the CD27+ NK cell subsets as is shown in Supplementary Fig. 1b. NK cells with high cMyc expression were found to be larger (FSC-A) and more proliferative (KI-67 staining) than NK cells with lower levels of cMyc expression, fitting with the described roles for cMyc in the control of cellular growth and proliferation (Fig. 2h, i). Taken together, NK cells upregulate the metabolic machinery after FV infection, which is important to support the metabolic demands of increased cell growth and proliferation during infection.
FV infection increases NK cell mitochondrial capacity
In cytokine-stimulated NK cells, the transcription factor cMyc is required to facilitate increased glycolytic and mitochondrial metabolism including cytokine-induced increases in mitochondrial mass7. Mitochondria generate chemical energy by converting nutrients and oxygen into adenosine triphosphate (ATP), necessary for all biochemical reactions. Here, we considered whether the observed increases in cMyc expression in NK cells following FV infection was linked to changes in mitochondrial mass, mitochondrial fitness and ATP levels. First, we analysed the ratio of the mitochondrial and nuclear DNA of isolated splenic NK cells from naive and FV-infected mice (7 dpi) to obtain information about the mitochondrial mass. After infection of mice with FV, the mt/nDNA ratio was significantly increased, indicating increased mitochondrial mass (Fig. 3a). Next, we analysed the mitochondrial membrane potential by analysing Tetramethylrhodamine, methyl ester (TMRM) staining (Fig. 3b, c). Oligomycin, which inhibits the ATP synthase, was used as a positive control as it induces the maximal polarisation of the mitochondrial membrane. FCCP, a mitochondrial membrane uncoupler, was used as a negative control as it depolarises the mitochondrial membrane. As shown in Fig. 3b, c, the mitochondrial membrane potential was significantly increased in NK cells after FV infection in comparison to NK cells from naive C57BL/6 mice in both analysed organs. Interestingly, the larger NK cells (FSChigh NK cells) had increased mitochondrial potential and mitochondrial mass in comparison to the smaller NK cells (FSClow NK cells) from infected mice, further supporting the argument that these larger NK cells have a metabolically active phenotype (Supplementary Fig. 1c). We also measured the cellular ROS levels in splenic and bone marrow NK cells and found no differences between the naive and infected groups (Fig. 3d). Considering that increased ROS levels can be associated with mitochondrial dysfunction, which has been observed for NK cells in certain pathological situations, we interpreted these normal ROS levels to suggest that NK cells during acute FV infection have healthy mitochondria. Indeed, this was further supported by the fact that NK cells from FV-infected mice had higher concentrations of ATP in comparison to NK cells from naive mice (Fig. 3e). For cytokine-activated NK cells, it has been shown previously that NK cells engage aerobic glycolysis plus high rates of oxidative phosphorylation (OXPHOS), a metabolic configuration that supports ATP production and provision of building blocks for biosynthesis6,8. Thus, we determined the extracellular acidification rates (ECAR) of splenic NK cells isolated ex vivo from naive and virus-infected mice (Fig. 3f). NK cells from infected mice exhibited increased ECAR rates in comparison to NK cells from naive mice. The calculation of basal glycolysis (Fig. 3g) and glycolytic capacity (Fig. 3h) confirmed the augmented glycolytic activity in NK cells from FV-infected animals. We also analysed the oxygen consumption rate (OCR) in splenic NK cells isolated from naive or virus-infected mice. As shown in Fig. 3i, j the basal OCR rate was significantly increased in NK cells from FV-infected mice in comparison to naive mice. NK cells from virus-infected mice also had enhanced rates of maximal respiration (Fig. 3k) and increased levels of ATP-linked respiration (Fig. 3l). The current data indicates that NK cells show increased cellular metabolism and elevated levels of the metabolic regulator cMyc during acute FV infection. Amino acid supply is crucial for metabolically active cells to support protein synthesis and other biosynthetic processes. Indeed, the uptake of amino acids through the system l-amino acid transporter has been shown to be important in NK cells stimulated with cytokines in vitro because it sustains elevated levels of cMyc protein7. This is because cMyc protein levels are balanced by rapid protein synthesis and rapid degradation via the ubiquitin-proteasome pathway32. Thus, in NK cells cMyc levels are acutely sensitive to amino acid availability7. Here, we assessed whether FV infection and increased cMyc expression were associated with increased transport of amino acids through system l-amino acid transporters in NK cells. There are four system l-amino acid transporters (LAT1-4) and in addition to large amino acids, they also transport kynurenine into the cell, which is naturally fluorescent and can be used to assess system l-amino acid transport activity by flow cytometry33. Thus, the analysis of kynurenine serves as a measure of amino acid uptake through the Slc7a5 transporter. System l-amino acid transporter consists of a common heavy chain subunit, CD98, and a light chain subunit that mediates the amino acid transport. In vitro cytokine-activated NK cells express only the light chain SLC7A5 (LAT1), but not SLC7A8 (LAT2), SLC43A1 (LAT3), SLC43A2 (LAT4), and so this kynurenine uptake assay serves as a measure of Slc7a5 amino acid uptake capacity7. Important controls including inhibitors of Slc7a5 and competition with other transported amino acids like leucine provide confidence in the specificity of this assay and are described in detail previously (Fig. 3m)33. Upon acute virus infection, there is an increase in the frequency of kynurenine+ NK cells and also an increased magnitude of kynurenine uptake in bone marrow NK cells, when compared to naive mice (Fig. 3n). We also analysed the subset of NK cells that take up kynurenine and we were able to show that mainly the double-positive (CD27+CD11b+) NK cell subset it taking up kynurenine (Supplementary Fig. 1b). The analysis of the heavy chain subunit CD98 reveals a high expression level of CD98 in bone marrow NK cells and an upregulation of CD98 in splenic NK cells after FV infection (Fig. 3o). Taken together, NK cells increase their ATP production correlating with dramatic changes in glycolytic and mitochondrial activity and demonstrate the increased activity of the l-amino acid transporters in NK cells from FV-infected mice.
Increased NK cell metabolism following acute MCMV infection
To understand whether metabolic changes were a general feature of NK cells responding to acute viral infection, experiments were carried out using mice infected with a virus from a different virus family, the murine cytomegalovirus (MCMV, herpesvirus). As expected, in MCMV-infected mice, splenic NK cells produced significant amounts of IFNγ (Fig. 4b), expressed high levels of granzyme B (Fig. 4c) and the activation marker CD69 (Fig. 4a). Similarly, with mice infected with FV, NK cells responding to acute MCMV infection had increased forward scatter, a measure of cell size (Fig. 4a, 2b). Likewise, with FV infection, NK cells also increase their CD71 (Fig. 4d) and CD98 (Fig. 4e) expression after MCMV infection. Transcriptomic analysis of nutrient transporters clearly showed increased numbers of several important nutrient transporter transcripts after MCMV infection, including the amino acid transporter Slc7a5, the glucose transporter Slc2a1, and the transferrin receptor CD71 (Fig. 4f). The transcriptional signatures also showed evidence of glycolytic reprogramming in NK cells after MCMV infection with a significant increase in the expression of glycolytic enzymes hexokinase 2 (Hk2), aldolase (Aldoa) and pyruvate kinase (Pkm) and glycolytic regulators Hif1α and Myc (Fig. 4f). Taken together, these data demonstrate that acute infection with the herpesvirus MCMV increases the metabolic parameters in NK cells similarly to the retrovirus infection (FV).
Decreased cytotoxicity in Slc7a5-knockout NK cells
It has been shown that the loss of the Slc7a5 transporter in T cells resulted in dysfunctional T cells, which could not metabolically reprogramme and did not differentiate and expand34. The previous data studying NK cells ex vivo have shown that the Slc7a5 transporter is important for NK cell signalling, metabolic activity and effector function7. To further explore the role of Slc7a5 in NK cells responding to FV infection, we used mice with loxP sites flanking exon 2 of the Slc7a5 gene crossed with transgenic mice expressing cre recombinase under the control of the NK cell-specific NCR1 promoter (hereafter called Slc7a5NK-KO)34,35. First, we examined NK cells from Slc7a5NK-KO mice and compared absolute NK cell numbers in spleen, bone marrow, blood and lymph nodes with NK cell numbers from Slc7a5NK-WT mice (Fig. 5a). We found similar absolute NK cell numbers from Slc7a5NK-WT and Slc7a5NK-KO mice in all organs analysed. Next, we determined the maturation status of NK cells by measuring CD27 and CD11b on NK cells (Fig. 5b). While there was a subtle shift in the balance between CD27+CD11b− and CD27+CD11b+ NK cell subsets in the bone marrow, there were no significant differences in the differentiation states of Slc7a5NK-WT and Slc7a5NK-KO NK cells in peripheral tissues such as the spleen (Fig. 5b). Then, we validated that cytokine-stimulated NK cells from the Slc7a5NK-KO mice were deficient for Slc7a5 activity by measuring kynurenine uptake into splenic NK cells (Fig. 5c). NK cells from Slc7a5NK-WT mice showed kynurenine uptake into splenic NK cells and a further increase when NK cells were stimulated with the cytokines IL-2/IL-12 overnight. In contrast, Slc7a5NK-KO NK cells were completely deficient for kynurenine uptake. We addressed the question of whether we can find differences in the expression of effector molecules and metabolic parameters at steady state in Slc7a5NK-WT and Slc7a5NK-KO mice (Supplementary Fig. 2a). No differences were detectable between WT and KO mice. Next, we infected knockout and control mice with FV and analysed the kynurenine uptake after infection (Fig. 5d). Slc7a5NK-WT NK cells were able to take up kynurenine whereas Slc7a5NK-KO mice lost the ability to take up kynurenine and showed similar levels as compared to the negative control BCH (System L blocker—no uptake of kynurenine). Additionally, we analysed the kynurenine uptake of T cells in FV-infected mice. T cells in Slc7a5NK-WT and Slc7a5NK-KO mice transported kynurenine and no differences were observed, thus verifying the NK cell specificity of the knockout (Supplementary Fig. 2b). Next, we analysed the absolute numbers of NK cells in Slc7a5NK-WT and Slc7a5NK-KO mice after FV infection (Fig. 5e). We detected significantly lower splenic and bone marrow NK cell numbers in Slc7a5NK-KO mice compared to Slc7a5NK-WT mice. Correlating with these data, we detected more proliferating KI-67+ NK cells (absolute numbers) in Slc7a5NK-WT mice in comparison to Slc7a5NK-KO mice in both analysed organs after retrovirus infection (Fig. 5f). However, the frequency of KI-67 positive NK cells from Slc7a5NK-WT and Slc7a5NK-KO mice was similar after FV infection (Supplementary Fig. 2c). Interestingly, NK cells from Slc7a5NK-WT and Slc7a5NK-KO mice exhibit comparable levels of activation and cytokine production, shown by CD69, TNF and IFNγ expression (Supplementary Fig. 2e). No differences in viability were detectable after FV infection in Slc7a5NK-WT and Slc7a5NK-KO mice (Supplementary Fig. 2d). Additionally, the overall IFNγ concentration in the serum of Slc7a5NK-WT and Slc7a5NK-KO mice were similar (Supplementary Fig. 2f). NK cell metabolic parameters such as the NK cell size, CD71, transferrin uptake, mitochondrial mass and polarisation and cMyc expression were also not significantly affected by the absence of Slc7a5 activity (Supplementary Fig. 2g). Next, we performed an in vitro cytotoxicity assay and co-incubated isolated NK cells from infected Slc7a5NK-WT and Slc7a5NK-KO mice with tumour cell targets (YAC-1, Fig. 5g) and FV-derived tumour cells (FBL-3, Fig. 5g). As expected, NK cells from FV-infected Slc7a5NK-WT mice had an increased killing capacity compared to cells from naive animals. However, NK cells from Slc7a5NK-KO mice showed significantly reduced levels of target cell killing compared to Slc7a5NK-WT cells. Next, we analysed the viral loads of FV-infected Slc7a5NK-WT and Slc7a5NK-KO mice (Fig. 5h). Although we detected the differences in target cell killing, there were no differences in the viral burden in infected Slc7a5NK-WT and Slc7a5NK-KO mice in both analysed organs. Collectively, these data show that the Slc7a5 transporter has an influence on NK cell numbers and cytotoxicity against YAC-1 target cells during viral infection but is not required for the overall NK cell antiviral response.
Iron availability is important for NK cell activity during FV infection
A well-characterised cMyc target gene is the transferrin receptor CD71, which is an important nutrient uptake receptor that mediates iron uptake via the endocytosis of transferrin-bound iron into the cell10. Iron is essential for cellular biochemistry, and T cell mitochondrial metabolism and effector functions are dependent on iron uptake12. Considering that CD71 expression was increased on NK cells in mice infected with MCMV (Fig. 4d), we hypothesised that iron uptake could be important for the NK cell response against retroviral infection. To analyse the uptake of iron into NK cells, we measured fluorescently labelled transferrin as an indicator of iron uptake by flow cytometry11. There was an increase in the uptake of transferrin into NK cells in FV-infected mice compared to NK cells from naive mice (Fig. 6a, b). Competition with unlabelled transferrin and performing the assay at 4 °C are important controls that provide confirmation in the specificity of this assay (Fig. 6a)11. Increased transferrin uptake and CD71 expression were observed in both NK cell populations from the bone marrow and the spleen following infection (Fig. 6b, c), suggesting that responding NK cells have an increased demand for iron. We showed that CD71 expression and transferrin uptake were mainly present by CD27+CD11b+ NK cells (Supplementary Fig. 1b). Viruses such as HIV alter iron levels and recent publications show that infection with SARS-CoV-2 result in hypoferremia36,37 but it remains unclear how these infection-associated shifts in iron availability might alter the outcome of viral infection38. Here we addressed the question of whether serum iron levels influence antiviral NK cell activity. Hepcidin is a hormone that prevents the export of iron into the serum by binding to the iron export channel protein ferroportin39. Elevated levels of hepcidin result in a reduction of serum iron. We used a synthesised polypeptide called mini-hepcidin that acts analogously to hepcidin to reduce iron levels in mice12,40. We injected mini-hepcidin in the vehicle DSPE or DSPE alone every day starting at the day of FV infection (Fig. 6d). The measurement of serum iron showed a more than ten-fold decrease of serum iron in mice receiving mini-hepcidin (Fig. 6e). Additionally, we detected increased CD71 expression on NK cells from infected, mini-hepcidin-treated mice in comparison to vehicle-treated, infected control mice indicating relative cellular iron deficiency (Fig. 6f), which is consistent with hypoferremia (Fig. 6e). Interestingly, the analysis of NK cell activation revealed a significant decrease of CD69+ NK cells in animals with reduced levels of serum iron upon acute FV infection in the spleen and bone marrow (Fig. 6g). Similarly, the percentage of IFNγ+ NK cells was decreased after mini-hepcidin treatment (Fig. 6h). The measurement of the overall IFNγ concentration in the serum of mice revealed a significant increase of IFNγ concentration in the serum of FV-infected mice compared to naive mice (Fig. 6i). After mini-hepcidin (mHep) treatment the IFNγ levels were significantly reduced compared with FV-infected mice and comparable with serum from naive mice. Due to the systemic inhibition of iron export into the serum using mHep, we addressed the question of whether NK cell functions are altered due to different levels of the cytokines responsible for NK cell activation in response to FV, including IL-15 and IL-184. In Fig. 6j, we were able to show that the cytokine concentrations were not decreased upon mHep treatment but in fact, IL-12, IL-15 and IL-18 levels were significantly increased. In line with Fig. 6h, i, we detected reduced mRNA levels of IFNγ and the IFNγ-induced chemokine CXCL10 in splenocytes (Fig. 6k), but we did not detect differences in the levels of the pro-inflammatory cytokines IL-2, IL-15 and IL-18, previously described to be important for NK cell activation upon FV infection and predominantly secreted by macrophages, DCs or CD4+ T cells4,18. Together, these data show that NK cells have an increased demand for iron when responding to acute FV infection and that experimental reduction of serum iron levels inhibits NK cell activation and their IFNγ production.
Iron deprivation inhibits NK cell responses against FV infection
We observed dramatic effects of iron deprivation on NK cell activation and cytokine production. We next assessed whether low iron concentrations have an influence on metabolic parameters of NK cells such as cell growth and cMyc expression. Thus, we analysed the NK cell forward scatter as a measure of NK cell size in low serum iron groups and control mice. We detected a smaller NK cell size in the FV-infected, iron-deprived group compared to FV-infected, vehicle-treated mice (Fig. 7a). The small cell size of these NK cells was comparable to that of NK cells from naive, vehicle-treated mice and was observed in both the spleen and bone marrow. We also discovered a dramatic decrease of cMyc+ NK cells in mice with low serum iron upon FV infection (Fig. 7b). To further explore the influence of iron deficiency on the NK cell capacity to kill target cells, we performed a cytotoxicity assay using FV-induced tumour cell targets (FBL-3 cells, Fig. 7c). NK cells isolated from infected mice with low serum iron levels showed significantly less killing of FBL-3 target cells than NK cells isolated from infected mice with normal serum iron levels. These NK cells eliminated approximately twice as many target cells as the iron-deprived NK cells. With the knowledge that low serum iron results in low activation, cytotoxicity and impaired metabolic reprogramming of NK cells, we then assessed the influence of low iron levels on viral loads of FV-infected mice (Fig. 7d). We observed significantly increased viral loads in the bone marrow, the main reservoir during initial viral infection, of mice treated with mini-hepcidin in comparison to vehicle-treated control mice. Considering that the levels of cytokines responsible for NK cells activating in FV-infected mice were not reduced in mice with low serum iron, we investigated whether limited iron availability has a direct effect on NK cells. Thus, we took advantage of in vitro expanded NK cells using an increasing concentration of an iron chelator deferoxamine (DFO) to decrease the iron content in the medium (Fig. 7e–h). To confirm that any observed effects of DFO were due to reduce iron availability a control was included with the highest dose of DFO supplemented with exogenous iron in the form of FeSO4. NK cells were stimulated with cytokines known to promote metabolic function and NK cell activation and there was a significant dose-dependent decrease in NK cell size (Fig. 7e), mitochondrial mass (Fig. 7f) as well as perforin (Fig. 7g) and granzyme B (Fig. 7h) in cultures with reduced iron levels. Importantly, adding back iron (FeSO4) in iron-deprived NK cell cultures restored these metabolic and functional outputs of NK cells. It has been shown previously that NK cell depletion and subsequent FV infection leads to increased viral loads, thus demonstrating the importance of NK cells in controlling this retrovirus41. Given the data showing that NK cells have impaired effector functions and metabolism in hypoferremic, FV-infected mice, we hypothesised that depleting NK cells from these mice would not affect viral loads because dysfunctional NK cells were not able to control FV infection. Therefore, we infected mice with FV and induced hypoferremia by repetitive injections of mHep. Additionally, one group of mice were depleted for NK cells. More than 92% of NK cells were depleted after the injections of NK cell depletion antibody NK1.1 (Fig. 7i). The analysis of the viral loads revealed no differences between the mHep-treated and mHep, NK cell-depleted groups (Fig. 7j). These data collectively show that sufficient serum iron is essential for NK cell metabolic responses and antiviral activity, and that serum iron deficiency can undermine the control of acute retroviral infection.
Viruses are the cause of numerous human diseases worldwide. The urgent need in understanding viral mechanisms and host responses as well as potential antiviral treatments are not only fundamental during the ongoing pandemic due to the new viral Coronavirus disease 2019 (COVID-19), but also for other viral infections that still cause health issues without vaccinations or cure (e.g. Dengue, Herpes simplex, HIV). Cellular metabolism is a very important parameter for multiple aspects of viral infection. Viruses such as HIV reprogram the cells that they infect towards increased levels of cellular metabolism, most notably increased glycolysis, as this increases the biosynthetic capacity of the cells to generated new viral particles42. As the study of immune metabolism reveals novel therapeutic strategies across all immunology fields, we wanted to understand the importance of metabolic processes for the antiviral functions of NK cells. As part of the innate immune system, NK cells respond rapidly and in vitro studies demonstrate that changes in metabolism are not required for the rapid (3–4 h) production of cytokines such as IFNγ and for NK cell-mediated cytotoxic killing of target cells43. However, NK cells can also operate over longer periods during antiviral responses and NK cells stimulated with cytokines for 24 h undergo clear metabolic changes that are essential for effector functions. Therefore, from the outset of this study, it was extremely uncertain whether cellular metabolism would be important for NK cells responding to acute FV infection in vivo during the innate phase of this antiviral response.
In this study, we demonstrate for the first time that there is increased metabolic reprogramming and nutrient uptake by NK cells responding to acute viral infections in vivo, in this case to acute Friend retrovirus (FV) infection and murine cytomegalovirus (MCMV). The data show that there is a distinct and robust metabolic response at the peak of the NK cell response to FV, at 7 dpi, that involved increased nutrient uptake and elevated rates of glycolysis and OXPHOS. NK cell glycolysis has previously been implicated in the response to MCMV infection as mice treated with 2-deoxyglucose (2DG), an inhibitor of glucose metabolism, showed increased MCMV viral burden44. However, it is worth noting that 2DG is not a specific inhibitor of glycolysis as 2DG inhibits other glucose-dependent processes including protein glycosylation. In FV-infected mice, NK cells show increased levels of cMyc protein, a metabolic regulator that has been shown to be important for mediating increased glycolysis and OXPHOS in ex vivo activated NK cells7. cMyc also regulates the capacity of cells to uptake key nutrients including amino acids and iron. The transferrin receptor CD71 is a well-characterised cMyc target gene, as are amino acid transporters including Slc1a5 and Slc7a5, important for the uptake of glutamine and large neutral amino acids, respectively10,45,46,47. Indeed, we show that in parallel with elevated cMyc expression, NK cells in FV-infected mice had increased expression of CD71 and associated transferrin uptake, as well as increased amino acid uptake through Slc7a5. It was previously shown that cMyc is required in NK cells for augmented glucose transporter expression and glycolytic enzymes as well as to support mitogenesis leading to increased mitochondrial mass7. During acute FV infection, cMyc expression in NK cells is associated with increased mitochondrial mass and membrane potential and elevated mitochondrial respiration. Taken together, it is clear that acute FV infection drives metabolic changes in NK cell characteristics of cMyc-mediated metabolic regulation.
Having characterised substantive metabolic changes in NK cells responding to FV, the functional importance of this NK cell metabolic phenotype was then investigated. Pharmacological inhibition of Slc7a5-mediated amino acid uptake has previously been shown to disrupt the function of NK cells stimulated with cytokines ex vivo7. A previous study by Sinclair et al. analysed the importance of Slc7a5 in T cells using a T cell-specific Slc7a5-knockout mouse34. They showed impaired T cell clonal expansion and effector differentiation as well as dysfunction in the metabolic reprogramming in Slc7a5-null T cells34. Here we have generated mice in which Slc7a5 is depleted specifically in NK cells. NK cells develop normally in these mice but show discrete defects following FV infection. In Slc7a5NK-KO mice infected with FV, we detected a significant decrease in NK cell numbers, which is not observed in Slc7a5NK-KO mice without infection. Interestingly, the NK cells show similar frequencies of KI-67 staining in Slc7a5NK-KO and Slc7a5NK-WT mice at 7 dpi, which marks cells that are engaging in cell cycling. In addition, the maturation stages of Slc7a5-null NK cells were similar to the Slc7a5-WT NK cells after FV infection (data not shown). Therefore, the reduced numbers of NK cells observed in FV-infected Slc7a5NK-KO mice may be due to reduced rates of cell cycle progression or alternatively to alterations in NK cell trafficking. Another possibility is that the NK cell response is delayed due to metabolic adaptation to the use of other amino acid transporters. This idea is supported by the observation that cMyc levels are not affected in Slc7a5-null NK cells in FV-infected mice. While cMyc can promote the expression of Slc7a5, it has also been shown in NK cells and T cells that amino acid uptake through Slc7a5 is important for the protein expression of cMyc7,34. In NK cells stimulated with cytokines ex vivo, blocking Slc7a5 activity results in the rapid loss of cMyc protein expression7. Therefore, cMyc and Slc7a5 activities are closely interconnected46. In Slc7a5-null NK cells from 7 days FV-infected mice, cytokine production, as well as metabolic factors such as cell size, transferrin uptake and cMyc, were similar to FV-infected Slc7a5NK WT mice despite the loss of amino acid uptake through Slc7a5. These data suggest that NK cells have adapted to uptake amino acids through alternative transporters to sustain cMyc protein expression or alternatively have adapted to using an alternative mechanism for cMyc regulation that is independent of amino acid availability. In contrast, Slc7a5-deficiency has a striking effect on the in vivo functions of T cells including cytokine production and granzyme B expression45. Taken together, these data suggest that NK cells possess a capacity for metabolic adaptation that T cells may lack. This idea is supported by a recent study that demonstrated NK cells have the capacity for metabolic adaptation in the absence of a key glycolytic enzyme, pyruvate kinase muscle isoform 2 (PKM2)48. Despite clear metabolic and functional defects in NK cells when PKM2 activity was manipulated in ex vivo cultured NK cells, mice lacking PKM2 specifically in NK cells showed completely normal immune responses to MCMV infection. However, while NK cells in FV-infected mice have adapted to maintain cMyc expression and cytokine production in the absence of Slc7a5, there are some clear functional consequences of Slc7a5 deletion as we observed lower cytotoxicity in Slc7a5-null NK cells during acute retroviral infection.
Another role of cMyc is the regulation and fine-tuning of transferrin receptor expression on immune cells, thus cMyc is important in controlling iron metabolism10,11. Iron is crucial for cellular processes such as DNA synthesis, DNA repair and multiple metabolic processes including OXPHOS. Systemic iron is tightly regulated by the hormone hepcidin. Dysregulation of iron homoeostasis can cause several diseases and viruses can also affect iron levels, which are linked to the severity of infections49. Recently it was reported that COVID-19 is associated with hypoferremia37 and viruses like hepatitis B, hepatitis C and HIV also alter iron homoeostasis36,49. After FV infection, NK cells upregulate the transferrin receptor and take up increased amounts of transferrin-bound iron. In this study, serum iron concentrations were suppressed by repetitive injections of mini-hepcidin and we analysed the impact of reduced serum iron on antiviral NK cell responses. Herein, we demonstrate that NK cells are very sensitive to serum iron deprivation, showing increased CD71 expression consistent with cellular iron deficiency. In contrast, macrophage- and DC-derived cytokines, such as IL-15 and IL-18, which are important in NK cell activation in FV-infected mice, were not decreased suggesting a direct effect of iron on NK cells. The data showed that in iron deficiency, NK cells have defects in their activation and metabolism, as the NK cells were small and had reduced cMyc levels that were comparable to those of NK cells from uninfected, control-treated mice. Similarly, when iron levels were reduced using the iron chelator deferoxamine during in vitro activation NK cells showed evidence of impaired metabolism and function, providing further evidence for a direct role of iron in facilitating NK cell responses. Interestingly, in iron-deficient mice infected with FV, we were able to show a dramatic decrease in NK cell cytotoxicity and observed an associated increase in bone marrow viral load, the organ of NK cell origin and high viral replication. While NK cells deficient in the expression of the amino acid transporter Slc7a5 showed a degree of metabolic plasticity that allowed NK cells to sustain much of their antiviral function, NK cells were not able to adapt to the low iron levels in mini-hepcidin treated mice. This likely reflects the fact that iron is a crucial biological metal required as a cofactor for numerous enzymes, most notable the complexes of the mitochondrial electron transport chain. Indeed, one of the clearest consequences of depleting iron with deferoxamine during in vitro NK cell activation was the inability of these NK cells to increase cellular mitochondrial mass.
These findings have important therapeutic implications, suggesting that iron supplementation may improve antiviral NK cell responses, especially in iron-deficient patients. It might also be interesting to determine whether NK cell metabolic activity and antiviral functions can be further augmented in iron-sufficient settings by iron supplementation or whether raised iron would have negative effects such as renal toxicity, cardiovascular and immunologic reactions or viral rebound50,51,52. However, the clinical use of iron preparations has increased in recent years and is worth exploring in the context of viral infection53.
Viruses such as CMV, hepatitis C and HIV require the host cell to facilitate the biosynthesis of new viral particles. The host cell iron level is important in the process54. These viruses remodel the iron uptake and/or processing within the host cells using various viral proteins55,56. In HIV infection accumulation of iron, mostly in macrophages, was shown to promote the HIV replication and is associated with poor outcome in HIV-1 infection57. Using iron chelators in order to lower the iron availability to infected cells suppressed viral replication using in vitro approaches54. For this reason, it has been proposed that lowering iron levels to disrupt the life cycle of the virus could be a beneficial therapeutic approach38. In our study, we make the novel discovery that serum iron deficiency has dramatic detrimental effects on the NK cell antiviral immune response and results in increased viral burden in vivo. Overall, this indicates that depriving immune cells of iron and limiting their antiviral functions has a greater negative impact on viral burden than any positive effects iron deficiency has through slowing viral replication in virus-infected cells. This is an important and novel finding that argues that reduced serum iron may contribute to poor outcomes for patients infected with retrovirus, at least in part due to disrupting NK cell responses. One limitation of this is model is that mini-hepcidin injection does not selectively deprive NK cells of iron and instead causes physiological serum iron deficiency which recapitulates the hypoferremia observed during some human infections. Therefore it will be interesting to examine to which extent experimentally induced iron deficiency perturbs the acute response to retroviral infections through direct effect on NK cells or via other immune cells. Interestingly we do not detect differences in the expression level of cytokines that have been shown previously to be highly important for supporting the activity of NK cells during acute FV infection4,18. mRNA levels for IL-15 and IL-18, produced by macrophages and dendritic cells and IL-2, secreted by activated CD4+ T cells, were equivalent in iron-deficient and iron-sufficient mice infected with FV. Independent of a direct or indirect effect, iron has a strong effect on the metabolic phenotype and the cytotoxicity of NK cells.
The currently used antiretroviral therapy (ART) for treating patients with HIV diminishes the viremia below the detection limit, but the eradication of HIV is still not possible. HIV-1 persists in cellular reservoirs and upon treatment interruption rapid viral rebound occurs58. During HIV infection, but also other persistent viral infections such as infections with FV, Lymphocytic choriomeningitis virus (LCMV), hepatitis B and hepatitis C, both cytotoxic CD8+ T cells and NK cells become dysfunctional and lose their cytotoxic potential59,60,61,62. Interestingly, CD8+ T cell and NK cell responses during persistent HIV infection can be reinvigorated with the pro-inflammatory cytokine IL-15, which had a beneficial effect on survival, memory formation and metabolic plasticity21,63,64,65. In this study, persistent HIV-infected individuals co-infected with HCMV have slight mitochondrial defects and less fuel flexibility in their adaptive NK cell population21. Herein we show that during acute retrovirus infection NK cells enhance their OXPHOS as well as their mitochondrial activity, resulting in increased ATP production. This increased energy generation is necessary to sustain the augmented proliferation and cytokine production of NK cells during acute infection. It seems that maintaining mitochondrial fitness is important for sustaining the antiviral activity of NK cells. Indeed, the induction of mitophagy, a process essential for clearing dysfunctional mitochondria has been shown to be crucial in NK cells response to MCMV infection in mice66. Therefore, it is tempting to speculate that targeting NK cell mitochondrial fitness may be an effective new therapeutic approach for retroviral infections.
C57BL/6, Slc7a5fl/fl (kindly provided by Linda Sinclair, University of Dundee, UK) and NCR1 Cre mice (kindly provided by Veronika Sexl, the University of Veterinary Medicine of Vienna, Austria) were bred in house. Male and female mice used in this study were on a C57BL/6 background and between 6 and 12 weeks of age. Mice were housed under 12:12 light cycle in a relative humidity of 45–65% and a temperature between 20 and 24 °C. Mouse experiments were approved and in compliance with the Irish Health Products Regulatory Authority and the Animal Research Ethics Committee (AREC) at Trinity College Dublin.
FV infection and Infectious Center assay
At least six-weeks-old mice were used for experiments. The FV complex containing B-tropic Friend murine leukaemia helper virus and polycythaemia-inducing spleen focus-forming virus was used for infections. Mice were injected intravenously with 0.1 ml phosphate-buffered saline (PBS) containing 40,000 SFFU of FV. The virus stock did not contain lactate dehydrogenase-elevating virus. Detection of infectious centres was done by 10-fold dilutions of single-cell suspensions (spleen, bone marrow) onto Mus dunni cells. For the bone marrow group, femur and tibia of hind legs were used. Cells were incubated for 72 h and fixed with EtOH. Cells were stained with the F-MuLV envelope-specific monoclonal antibody 720, and developed with a peroxidase-conjugated goat anti-mouse antibody (1:400, 115-035-003, Dianova). Finally, cells were incubated with aminoethylcarbazol (A6926-100TAB, Sigma) and washed with water for the detection of foci.
Surface and viability stains were done at room temperature for 20 min in the dark. Cells were fixed with Cyto-Fast Fix-Perm Buffer Set (426803, BioLegend) and stained intracellular in corresponding buffer. For intranuclear staining, cells were fixed with Foxp3/Transcription Factor Fixation/Permeabilization Kit (00-5523-00, eBioscience). Cells were restimulated with ionomycin (500 ng/ml, I9657, Sigma), phorbol myristate acetate (PMA; 100 ng/ml, P8139, Sigma), BFA (5 µg/ml, 420601, BioLegend), Monensin (2 µg/ml), 420701, BioLegend, diluted in supplemented RPMI buffer at 37 °C for 3 h. Dead cells were excluded using Zombie Aqua (1:1000, 423102, BioLegend). Cells were analysed with Canto II flow cytometer (BD) and BD DIVA 8.0 software. Antibodies used as follows: CD3 (17A2, FITC, 1:200, 100204, BioLegend), CD11b (M1/70, PE Cy7, 1:400, 101216, BioLegend), CD27 (LG.3A10, PE, 1:200, 558754, BD Pharmingen), CD49b (DX5, APC-Vio 770, 1:200, 130-105-249, Miltenyi Biotech), CD69 (H1.2F3, PerCP-Cy5.5, 1:200, 561931, BD Pharmingen), CD71 (R17217, APC, 1:200, 17-0711-82, eBioscience), CD98 (RL388, PE, 1:200, 12-0981-81, eBioscience), cMyc (D84C12, PE, 1:100, 14819, Cell Signaling), FasL (MFL3, PerCP-eFluor 710, 1:200, 46-5911-82, eBioscience), GzmB (NGZB, PE Cy7, 1:200, 25-8898-82, eBioscience), IFNγ (XMG1.2, APC, 1:100, 554413 BD Pharmingen), KI-67 (REA183, PE-Vio770, 1:200, 130-120-419, Miltenyi Biotech), NK1.1 (PK136, BV421, 1:200, 108732, BioLegend), Ter119 (TER-119, BV510, 1:200, 116237, BioLegend), TNF (MP6-XT22, PE Cy7, 1:100, 25-7321-82, eBioscience).
Cells were resuspended in complete RPMI plus Tetramethylrhodamine, methyl ester (TMRM, 100 nM, T668, Invitrogen) and MitoTracker Green (MTG, 100 nM, M7514, Invitrogen) and incubated for 20 min at 37 °C. As a control, Oligomycin (2 µM, Sigma) and FCCP (20 µM, Sigma) was added to cells. For CellROX staining (C10491, Invitrogen), controls were incubated with Tert-butyl Hydroperoxide (TBHP, 200 µM) for 1 h at 37 °C. CellROX was added for 20 min at 37 °C (5 µM). Cells were measured without fixation. Data were analysed with FlowJo Version 10.
Cells were washed with serum-free RPMI supplemented with 0.5% BSA twice. Spleen cells were incubated with or without 5 μg/ml of Alexa Fluor 647-conjugated Transferrin (T23366, Invitrogen) for 10 min at 37 °C. Holo-transferrin (500 µg/ml, T4132, Sigma) was added to controls. Uptake was stopped by washing twice with ice-cold acid wash (PBS supplemented with 150 mM NaCl and 20 mM citric acid, pH 5) and then with ice-cold RPMI + 0.5% BSA. Cells were stained for surface markers and analysed by flow cytometry.
HBSS was pre-warmed to 37 °C and kynurenine (final concentration 200 μM, K8525, Sigma), BCH (final 10 mM, A7902, Sigma), leucine (final 5 mM, L8912, Sigma) and lysine (final 5 mM, L8662, Sigma) was prepared. After surface antibody staining of samples, cells were resuspended in pre-warmed HBSS. Kynurenine and/or control reagents were added and samples were kept at 37 °C. The uptake was stopped after 5 min by adding 4% PFA for 30 min at room temperature, in the dark. Samples were measured at Canto II (BD, 405 nm laser, 450/50 BP filter for kynurenine fluorescence detection).
Seahorse analysis of ECAR and OCR
For real-time analysis of the extracellular acidification rate (ECAR) and oxygen consumption rate (OCR) of NK cells ex vivo, NK cells were isolated from spleens of naive and FV-infected mice. All wells were treated with Cell-Tak (734-1081, Corning) to ensure that the NK cells adhere to the plate. 200,000 isolated NK cells were plated per well and analysed by Seahorse XFe-96 Analyser (Agilent Technologies, Santa Clara, CA, USA). Sequential measurements of ECAR and OCR following the addition of the inhibitors (Sigma) oligomycin (2 μM, O4876), FCCP (1 μM, C2920), rotenone (100 nM, R8875) plus antimycin A (4 μM, A8674), and 2-deoxyglucose (2DG, 30 mM, 111980050, Acros Organics) enabled the calculation of basal glycolysis, glycolytic capacity, basal mitochondrial respiration, ATP production and maximal mitochondrial respiration.
NK cells were washed twice with PBS and lysed in Glo Lysis Buffer (E2661, Promega). ATP detection with ATP Determination Kit (A22066, Invitrogen) was done according to the manufacturer’s instructions.
NK cell isolation and depletion
NK cell enrichment was done with MojoSort Mouse NK Cell Isolation Kit (480050, BioLegend) according to the manufacturer’s instructions. NK cells were depleted by i.p. injections of 10 µg purified anti-NK1.1 depletion antibody (clone PK136, BE0036, BioXcell). The injection was done one day before FV infection and one day after infection.
In vitro cytotoxicity assay
Isolated, splenic NK cells (25 × 104) from different groups were co-incubated with Tag-It Violet Tracking Dye (425101, BioLegend) stained YAC-1 and FBL-3 tumour cells (1 × 104). The cytotoxic assay was performed in 96-well U-bottom plates. The cells were co-incubated for 18 h in a humidified 5% CO2 atmosphere at 37 °C. Cells were washed once and stained with Zombie NIR (423106, BioLegend) to exclude dead cells. After a wash, cells were directly analysed by flow cytometry.
Cytokines were detected with a custom-made Legendplex kit (according to the manufacturer’s instructions (BioLegend)).
RNA expression by array was reanalysed from GSE39555 using the Phantasus web platform version 1.12.0 (https://artyomovlab.wustl.edu/phantasus). Differential expression analysis was performed using LIMMA version 4.1. and significantly upregulated nutrient transporters and glycolysis-related genes were plotted.
Isolated NK cells were stored in DNA/RNA Shield (R1100, Zymoresearch). DNA was isolated with the Quick-DNA Microprep Kit (D3020, Zymoresearch). Real-time PCR was performed in duplicates using the PerfeCTa SYBR Green Supermix (95054, Quanta Bio). Relative changes in DNA were calculated by ΔΔCt method: 2^−([Ct mtDNAFV − Ct nDNAFV] )− [(Ct mtDNAnaive − Ct nDNAnaive)] (Supplementary Table 1).
RNA was extracted from liver explants harvested into RNA later (AM7021, ThermoFisher Scientific) and the RNeasy Plus kit (74034, Qiagen). RNA was transcribed to cDNA (4387406, Life Technologies) for quantitative PCR on the Applied Biosystems 6500 Fast Real-Time PCR system machine using TaqMan assays according to the manufacturer’s protocols. Gene expression is presented as 2^([Ct of endogenous control gene] − [Ct of gene of interest]). Hprt was used as an endogenous control gene for liver qRT-PCR (Mm01545399_m1, ThermoFisher).
Mice were injected intraperitoneally with 100 nmol of mini-hepcidin PR73 (Ida-TH-Dpa-bhPro-RCR-bhPhe-Ahx-Ida(Hexadecylamine)-NH2) dissolved in 100 μl of DSPE (SUNBRIGHT DSPE-020CN, a PEG-phospholipid based solubilizer, NOF Corporation), whereas naive and FV-infected control groups were injected with the same amount of solvent. Injections were done every day at the same time.
Analysis of serum iron
Murine blood was placed in a BD microtainer SST tube (365968, Beckton Dickinson). Serum was obtained by spinning the clotted blood sample was spun at 8000×g for 5 min and stored at −80 °C. Serum iron was quantified using the Abbott Architect c16000 automated analyser (Abbott Laboratories) and the MULTIGENT Iron Kit at Oxford John Radcliffe Hospital, UK, or at Atellica CH 930 Analyzer (Siemens Healthineers) and Iron_2 method at University Hospital Essen, Germany.
In vitro NK cell culture
Splenocytes were isolated from naive C57BL/6 mice and cultured for 6 days in 10 ng/ml IL-15. On day 4, iron availability was modified by adding DFO (4, 20, 100 µM, D9533, Sigma). On day 6, IL-2, IL-12 and FeSO4 (200 µM, F8633, Sigma/Merck) was added, if indicated.
Statistics were calculated and graphs prepared with GraphPad Prism version 8 and Excel 2016. Statistical differences between two different groups were determined by Mann–Whitney test (nonparametric) or unpaired t-test (parametric). Analyses including several groups were tested using the nonparametric Kruskal–Wallis one-way analysis of variance (ANOVA) on ranks and Dunn’s multiple-comparison test (nonparametric) or ordinary one-way ANOVA and Tukey multiple-comparison test (parametric). For the determination of correlating variables, linear regression and Goodness of fit were performed.
Further information on research design is available in the Nature Research Reporting Summary linked to this article.
The authors declare that the data supporting the findings of this study are available within the paper. The source of RNA expression by the array (Affymetrix Mouse Genome 430 2.0 Array) is GSE39555. RNA expression by array data was accessed online: GSM9716290 [https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSM971629], GSM971641, GSM971631, and GSM971643. Source data are provided with this paper.
Vivier, E., Tomasello, E., Baratin, M., Walzer, T. & Ugolini, S. Functions of natural killer cells. Nat. Immunol. 9, 503–510 (2008).
Lanier, L. L. Activating and inhibitory NK cell receptors. Adv. Exp. Med. Biol. 452, 13–18 (1998).
Nguyen, K. B. et al. Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection. J. Immunol. 169, 4279–4287 (2002).
Littwitz-Salomon, E., Schimmer, S. & Dittmer, U. The dose of retroviral infection determines the induction of anti-viral NK cell responses. J. Virol. https://doi.org/10.1128/JVI.01122-17 (2017).
Biron, C. A., Nguyen, K. B., Pien, G. C., Cousens, L. P. & Salazar-Mather, T. P. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17, 189–220 (1999).
Assmann, N. et al. Srebp-controlled glucose metabolism is essential for NK cell functional responses. Nat. Immunol. 18, 1197–1206 (2017).
Loftus, R. M. et al. Amino acid-dependent cMyc expression is essential for NK cell metabolic and functional responses in mice. Nat. Commun. 9, 2341 (2018).
Donnelly, R. P. et al. mTORC1-dependent metabolic reprogramming is a prerequisite for NK cell effector function. J. Immunol. 193, 4477–4484 (2014).
Cronin, S. J. F., Woolf, C. J., Weiss, G. & Penninger, J. M. The role of iron regulation in immunometabolism and immune-related disease. Front. Mol. Biosci. 6, 116 (2019).
O’Donnell, K. A. et al. Activation of transferrin receptor 1 by c-Myc enhances cellular proliferation and tumorigenesis. Mol. Cell Biol. 26, 2373–2386 (2006).
Preston, G. C. et al. Single cell tuning of Myc expression by antigen receptor signal strength and interleukin-2 in T lymphocytes. EMBO J. 34, 2008–2024 (2015).
Frost, J. N. et al. Hepcidin-mediated hypoferremia disrupts immune responses to vaccination and infection. Medicine https://doi.org/10.1016/j.medj.2020.10.004 (2020).
Michelet, X. et al. Metabolic reprogramming of natural killer cells in obesity limits antitumor responses. Nat. Immunol. 19, 1330–1340 (2018).
Chesebro, B., Miyazawa, M. & Britt, W. J. Host genetic control of spontaneous and induced immunity to Friend murine retrovirus infection. Annu. Rev. Immunol. 8, 477–499 (1990).
Littwitz-Salomon, E., Dittmer, U. & Sutter, K. Insufficient natural killer cell responses against retroviruses: how to improve NK cell killing of retrovirus-infected cells. Retrovirology 13, 77 (2016).
Littwitz, E., Francois, S., Dittmer, U. & Gibbert, K. Distinct roles of NK cells in viral immunity during different phases of acute Friend retrovirus infection. Retrovirology 10, 127 (2013).
Littwitz-Salomon, E., Malyshkina, A., Schimmer, S. & Dittmer, U. The cytotoxic activity of natural killer cells is suppressed by IL-10(+) regulatory T cells during acute retroviral infection. Front. Immunol. 9, 1947 (2018).
Littwitz-Salomon, E. et al. Activated regulatory T cells suppress effector NK cell responses by an IL-2-mediated mechanism during an acute retroviral infection. Retrovirology 12, 66 (2015).
Littwitz-Salomon, E., Nguyen, T., Schimmer, S. & Dittmer, U. Friend retrovirus infection induces the development of memory-like natural killer cells. Retrovirology 15, 68 (2018).
Reeves, R. K. et al. Antigen-specific NK cell memory in rhesus macaques. Nat. Immunol. 16, 927–932 (2015).
Cubero, E. et al. IL-15 re-programming compensates for NK cell mitochondrial dysfunction 1 in HIV-1 infection. Preprint at bioRxiv https://doi.org/10.1101/811117 (2019).
Berod, L. et al. De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells. Nat. Med 20, 1327–1333 (2014).
Lee, C. F. et al. Preventing allograft rejection by targeting immune metabolism. Cell Rep. 13, 760–770 (2015).
Assmann, N. & Finlay, D. K. Metabolic regulation of immune responses: therapeutic opportunities. J. Clin. Invest. 126, 2031–2039 (2016).
Zelinskyy, G. et al. The regulatory T-cell response during acute retroviral infection is locally defined and controls the magnitude and duration of the virus-specific cytotoxic T-cell response. Blood 114, 3199–3207 (2009).
Dittmer, U. et al. Essential roles for CD8+ T cells and gamma interferon in protection of mice against retrovirus-induced immunosuppression. J. Virol. 76, 450–454 (2002).
Rein, A. Murine leukemia viruses: objects and organisms. Adv. Virol. 2011, 403419 (2011).
Zelinskyy, G., Kraft, A. R., Schimmer, S., Arndt, T. & Dittmer, U. Kinetics of CD8+ effector T cell responses and induced CD4+ regulatory T cell responses during Friend retrovirus infection. Eur. J. Immunol. 36, 2658–2670 (2006).
Chiossone, L. et al. Maturation of mouse NK cells is a 4-stage developmental program. Blood 113, 5488–5496 (2009).
O’Brien, K. L. & Finlay, D. K. Immunometabolism and natural killer cell responses. Nat. Rev. Immunol. 19, 282–290 (2019).
Morrish, F., Isern, N., Sadilek, M., Jeffrey, M. & Hockenbery, D. M. c-Myc activates multiple metabolic networks to generate substrates for cell-cycle entry. Oncogene 28, 2485–2491 (2009).
Gregory, M. A. & Hann, S. R. c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt’s lymphoma cells. Mol. Cell Biol. 20, 2423–2435 (2000).
Sinclair, L. V., Neyens, D., Ramsay, G., Taylor, P. M. & Cantrell, D. A. Single cell analysis of kynurenine and System L amino acid transport in T cells. Nat. Commun. 9, 1981 (2018).
Sinclair, L. V. et al. Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation. Nat. Immunol. 14, 500–508 (2013).
Eckelhart, E. et al. A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development. Blood 117, 1565–1573 (2011).
Armitage, A. E. et al. Distinct patterns of hepcidin and iron regulation during HIV-1, HBV, and HCV infections. Proc. Natl Acad. Sci. USA 111, 12187–12192 (2014).
Shah, A. et al. Systemic hypoferremia and severity of hypoxemic respiratory failure in COVID-19. Crit. Care 24, 320 (2020).
Drakesmith, H. & Prentice, A. M. Hepcidin and the iron-infection axis. Science 338, 768–772 (2012).
Drakesmith, H., Nemeth, E. & Ganz, T. Ironing out ferroportin. Cell Metab. 22, 777–787 (2015).
Ramos, E. et al. Minihepcidins prevent iron overload in a hepcidin-deficient mouse model of severe hemochromatosis. Blood 120, 3829–3836 (2012).
Littwitz-Salomon, E., Schimmer, S. & Dittmer, U. Dose of retroviral infection determines induction of antiviral NK cell responses. J. Virol. 91, https://doi.org/10.1128/JVI.01122-17 (2017).
Hegedus, A., Kavanagh Williamson, M. & Huthoff, H. HIV-1 pathogenicity and virion production are dependent on the metabolic phenotype of activated CD4+ T cells. Retrovirology 11, 98 (2014).
Keppel, M. P., Saucier, N., Mah, A. Y., Vogel, T. P. & Cooper, M. A. Activation-specific metabolic requirements for NK Cell IFN-gamma production. J. Immunol. 194, 1954–1962 (2015).
Mah, A. Y. et al. Glycolytic requirement for NK cell cytotoxicity and cytomegalovirus control. JCI Insight 2, https://doi.org/10.1172/jci.insight.95128 (2017).
Marchingo, J. M., Sinclair, L. V., Howden, A. J. & Cantrell, D. A. Quantitative analysis of how Myc controls T cell proteomes and metabolic pathways during T cell activation. Elife 9, https://doi.org/10.7554/eLife.53725 (2020).
Yue, M., Jiang, J., Gao, P., Liu, H. & Qing, G. Oncogenic MYC activates a feedforward regulatory loop promoting essential amino acid metabolism and tumorigenesis. Cell Rep. 21, 3819–3832 (2017).
Wise, D. R. et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc. Natl Acad. Sci. USA 105, 18782–18787 (2008).
Walls, J. F. et al. Metabolic but not transcriptional regulation by PKM2 is important for natural killer cell responses. Elife 9, https://doi.org/10.7554/eLife.59166 (2020).
Schmidt, S. M. The role of iron in viral infections. Front Biosci. 25, 893–911 (2020).
Fishbane, S., Mathew, A. & Vaziri, N. D. Iron toxicity: relevance for dialysis patients. Nephrol. Dial. Transpl. 29, 255–259 (2014).
Vaziri, N. D. Understanding iron: promoting its safe use in patients with chronic kidney failure treated by hemodialysis. Am. J. Kidney Dis. 61, 992–1000 (2013).
Clark, T. D. & Semba, R. D. Iron supplementation during human immunodeficiency virus infection: a double-edged sword? Med Hypotheses 57, 476–479 (2001).
Geisser, P. & Burckhardt, S. The pharmacokinetics and pharmacodynamics of iron preparations. Pharmaceutics 3, 12–33 (2011).
Drakesmith, H. & Prentice, A. Viral infection and iron metabolism. Nat. Rev. Microbiol. 6, 541–552 (2008).
Vahdati-Ben Arieh, S. et al. A single viral protein HCMV US2 affects antigen presentation and intracellular iron homeostasis by degradation of classical HLA class I and HFE molecules. Blood 101, 2858–2864 (2003).
Drakesmith, H. et al. HIV-1 Nef down-regulates the hemochromatosis protein HFE, manipulating cellular iron homeostasis. Proc. Natl Acad. Sci. USA 102, 11017–11022 (2005).
McDermid, J. M. et al. Elevated iron status strongly predicts mortality in West African adults with HIV infection. J. Acquir. Immune Defic. Syndr. 46, 498–507 (2007).
Finzi, D. et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278, 1295–1300 (1997).
Kahan, S. M., Wherry, E. J. & Zajac, A. J. T cell exhaustion during persistent viral infections. Virology 479-480, 180–193 (2015).
Alter, G. et al. Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection. Blood 106, 3366–3369 (2005).
Hu, P. F. et al. Natural killer cell immunodeficiency in HIV disease is manifest by profoundly decreased numbers of CD16+ CD56+ cells and expansion of a population of CD16dimCD56- cells with low lytic activity. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 10, 331–340 (1995).
Gonzalez, V. D. et al. Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment. J. Immunol. 183, 6612–6618 (2009).
Angin, M. et al. Metabolic plasticity of HIV-specific CD8(+) T cells is associated with enhanced antiviral potential and natural control of HIV-1 infection. Nat. Metab. 1, 704–716, https://doi.org/10.1038/s42255-019-0081-4 (2019).
Mueller, Y. M. et al. Interleukin-15 increases effector memory CD8+ T cells and NK cells in simian immunodeficiency virus-infected macaques. J. Virol. 79, 4877–4885 (2005).
Freeman, G. J., Wherry, E. J., Ahmed, R. & Sharpe, A. H. Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade. J. Exp. Med. 203, 2223–2227 (2006).
O’Sullivan, T. E., Johnson, L. R., Kang, H. H. & Sun, J. C. BNIP3- and BNIP3L-mediated mitophagy promotes the generation of natural killer cell memory. Immunity 43, 331–342 (2015).
E.L.-S. is supported by a grant from the German Research Foundation (DFG) LI 3282/1-1. The DKFlab is supported by funding from the European research council (ERC-CoG 770769) and Science Foundation Ireland (18/ERCS/6005). C.C. is supported by an Irish Research Council Government of Ireland Postgraduate Scholarship (GOIPG/2018/2700). The Drakesmith lab is supported by the UK Medical Research Council.
Open Access funding enabled and organized by Projekt DEAL.
The authors declare no competing interests.
Peer review information Nature Communications thanks Christian Munz and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Peer reviewer reports are available.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Littwitz-Salomon, E., Moreira, D., Frost, J.N. et al. Metabolic requirements of NK cells during the acute response against retroviral infection. Nat Commun 12, 5376 (2021). https://doi.org/10.1038/s41467-021-25715-z